Skip to main content
OpenTrials

Clinical trial condition

Meningeal Neoplasms

Explore clinical trials studying Meningeal Neoplasms. Study availability and eligibility vary by location and protocol.

271 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Meningeal Neoplasms trial results

Recruiting

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

NCT07533942

Conditions
Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +7 more
Locations
  • Sutter Health San Francisco, California, United States
  • Louisiana State University New Orleans, Louisiana, United States
  • Mass General Boston, Massachusetts, United States
  • NYU- Langone Health New York, United States
View Trial Details
Recruiting

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

NCT07428616

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +10 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo Clinic_Arizona Phoenix, Arizona, United States
  • Mayo Clinic_Jacksonville Jacksonville, Florida, United States
  • Baptist Health Miami Cancer Institute Miami, Florida, United States
View Trial Details
Recruiting

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

NCT05278208

Conditions
Anaplastic Ependymoma, Brain Diseases, Brain Neoplasms, +32 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

NCT05184816

Conditions
Central Nervous System Neoplasms, Disease Attributes, Leptomeningeal Metastases, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

NCT02523014

Conditions
Central Nervous System Neoplasms, Intracranial Meningioma, Meningeal Neoplasms, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 780 locations
View Trial Details
Recruiting

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

NCT03180268

Conditions
Central Nervous System Neoplasms, Grade 2 Meningioma, Intracranial Meningioma, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
View all 215 locations
View Trial Details

Related conditions